Artwork

Sisällön tarjoaa ICR. ICR tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Chris Hall, CEO and President, Personalis Inc. – A Prescription for Prosperity: Fueling medical breakthroughs with cutting-edge tech and strategic alliances

29:50
 
Jaa
 

Manage episode 409062361 series 3281544
Sisällön tarjoaa ICR. ICR tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Big healthcare challenges demand cutting-edge healthcare products. Today's guest is building strategic partnerships to get ahead of disease and fuel the growth of their company.

Today we're sitting down with Chris Hall, CEO and President of Personalis, which trades under the symbol PSNL. In his role, Chris drives the vision and strategy for the company, including commercializing its diagnostic product offerings. He brings over 20 years of experience in general management and product development within the diagnostics industry, most recently as CEO of Naring Health.

Previously he served as President, COO, and Chief Commercial Officer of Veracyte Inc, where he led the company's commercial entry into endocrinology and pulmonology and scaled its operational groups. Chris also served as an SVP and Chief Business Officer at Berkeley HeartLab, part of Celera Corporation, where he helped new product launches, and restructured operations to improve profitability and streamline delivery of services.

Chris holds a BA in political science from DePauw University and an MBA from Harvard.

Highlights:

  • Chris describes Personalis and their work (3:45)
  • Personalis' MRD test and how it works (6:25)
  • Chris walks us through Personalis' tech evolution (8:23)
  • Personalis' current partnerships and collaborations (10:24)
  • More about the internal team at Personalis (14:31)
  • Chris discusses Personalis' recent Medicare coverage announcement (16:09)
  • The current macro environment's effect on business (18:09)
  • 2023 highlights at Personalis (19:54)
  • Near-future growth and development goals for Personalis (22:25)
  • Leadership and company culture at Personalis (24:22)
  • Product development and long-term objectives (26:19)

Links:

Chris Hall on LinkedIn

Personalis on LinkedIn

Personalis Website

ICR LinkedIn

ICR Twitter

ICR Website

Feedback:

If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, marion@lowerstreet.co.

  continue reading

133 jaksoa

Artwork
iconJaa
 
Manage episode 409062361 series 3281544
Sisällön tarjoaa ICR. ICR tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Big healthcare challenges demand cutting-edge healthcare products. Today's guest is building strategic partnerships to get ahead of disease and fuel the growth of their company.

Today we're sitting down with Chris Hall, CEO and President of Personalis, which trades under the symbol PSNL. In his role, Chris drives the vision and strategy for the company, including commercializing its diagnostic product offerings. He brings over 20 years of experience in general management and product development within the diagnostics industry, most recently as CEO of Naring Health.

Previously he served as President, COO, and Chief Commercial Officer of Veracyte Inc, where he led the company's commercial entry into endocrinology and pulmonology and scaled its operational groups. Chris also served as an SVP and Chief Business Officer at Berkeley HeartLab, part of Celera Corporation, where he helped new product launches, and restructured operations to improve profitability and streamline delivery of services.

Chris holds a BA in political science from DePauw University and an MBA from Harvard.

Highlights:

  • Chris describes Personalis and their work (3:45)
  • Personalis' MRD test and how it works (6:25)
  • Chris walks us through Personalis' tech evolution (8:23)
  • Personalis' current partnerships and collaborations (10:24)
  • More about the internal team at Personalis (14:31)
  • Chris discusses Personalis' recent Medicare coverage announcement (16:09)
  • The current macro environment's effect on business (18:09)
  • 2023 highlights at Personalis (19:54)
  • Near-future growth and development goals for Personalis (22:25)
  • Leadership and company culture at Personalis (24:22)
  • Product development and long-term objectives (26:19)

Links:

Chris Hall on LinkedIn

Personalis on LinkedIn

Personalis Website

ICR LinkedIn

ICR Twitter

ICR Website

Feedback:

If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, marion@lowerstreet.co.

  continue reading

133 jaksoa

Semua episod

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas